Andrew Barrett


Information taken from:


As Vice President, Scientific Affairs, Dr. Barrett is responsible for leading KemPharm’s medical communications strategies and contributing to the clinical/regulatory development of the company’s pipeline assets. Widely regarded as an expert in CNS pharmacology and therapeutics, Dr. Barrett brings nearly 20 years’ experience in academia and industry to KemPharm, having joined the company in February 2016 as Senior Director, Scientific Affairs.

Prior to joining KemPharm, Dr. Barrett was Senior Director, Medical Affairs at Chimerix, Inc., Director, Medical Affairs at Salix Pharmaceuticals and Medical Director at Synchrony Healthcare. Previous to that he worked at Cephalon, Inc. for more than five years in several positions of escalating seniority from Medical Science Liaison to Director, Medical Science Liaisons.

Dr. Barrett earned his Ph.D. in Neuroscience at University of North Carolina at Chapel Hill, and completed postdoctoral training at Harvard Medical School/McLean Hospital where he studied the abuse-related effects of stimulants and opioids.

Average: 5 (1 vote)
Rating for this content